期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Zinc-doped Prussian blue nanoparticles for mutp53-carrying tumor ion interference and photothermal therapy
1
作者 Quanyi Jin Wenbao Zuo +5 位作者 Qian Lin Ting Wu Cong Liu Nian Liu Jinxue Liu Xuan Zhu 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2022年第5期767-777,共11页
Quite a great proportion of known tumor cells carry mutation in TP53 gene,expressing mutant p53 proteins(mutp53)missing not only original genome protective activities but also acquiring gain-of-functions that favor tu... Quite a great proportion of known tumor cells carry mutation in TP53 gene,expressing mutant p53 proteins(mutp53)missing not only original genome protective activities but also acquiring gain-of-functions that favor tumor progression and impede treatment of cancers.Zinc ions were reported as agents cytocidal to mutp53-carrying cells by recovering p53 normal functions and abrogating mutp53.Meanwhile in a hyperthermia scenario,the function of wild type p53 is required to ablate tumors upon heat treatment hence the effects might be hindered in a mutp53 background.We herein synthesized zinc-doped Prussian blue(ZP)nanoparticles(NPs)to combine Zn 2+based and photothermal therapeutic effects.An efficient release of Zn 2+in a glutathione-enriched tumor intracellular microenvironment and a prominent photothermal conversion manifested ZP NPs as zinc ion carriers and photothermal agents.Apoptotic death and autophagic mutp53 elimination were found to be induced by ZP NPs in R280K mutp53-containing MDA-MB-231 cells and hyperthermia was rendered to ameliorate the treatment in vitro through further mutp53 elimination and increased cell death.The combinatorial therapeutic effect was also confirmed in vivo in a mouse model.This study might expand zinc delivery carriers and shed a light on potential interplay of hyperthermia and mutp53 degradation in cancer treatment. 展开更多
关键词 ZINC Mutant p53 Prussian blue Photothermal therapy ion interference therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部